Related Experiment Video
Updated: Jun 9, 2025
09:01
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
14.1K
Inclusion body myositis: an update
Nicolaas C Anderson1, Thomas E Lloyd
1Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
Current Opinion in Rheumatology
|October 29, 2024
Summary
Recent advances in inclusion body myositis (IBM) reveal its significant morbidity and mortality, particularly with dysphagia. New multiomic insights are guiding biomarker discovery and therapeutic targets, though exercise remains the main treatment.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Inclusion body myositis (IBM) is a progressive, debilitating neuromuscular disorder.
- Understanding its epidemiology, pathophysiology, and management is crucial for patient care and research.
Purpose of the Study:
- To review recent scientific advances in inclusion body myositis (IBM).
- To highlight new findings in epidemiology, pathophysiology, and management strategies.
Main Methods:
- Literature review of recent epidemiologic studies.
- Analysis of multiomic data from IBM tissues.
- Evaluation of proposed diagnostic criteria and outcome measures.
- Review of ongoing clinical trials targeting specific pathways.
Main Results:
- Epidemiologic studies confirm significant morbidity and mortality in IBM, including dysphagia impact.
- Multiomic analyses reveal novel pathogenic pathways and potential biomarkers.
- New diagnostic criteria and outcome measures aim to enhance clinical trial design.
- Current trials focus on T cell and autophagy pathways.
Conclusions:
- Further validation of identified pathways and biomarkers in larger cohorts is necessary.
- While exercise is the primary therapy, novel treatment targets for IBM are urgently needed.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:27Myocarditis II: Clinical features and Diagnostic Tests
2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
01:21Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
01:15Myasthenia Gravis: Diagnostic Tests
673
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
673